Waiting
Traitement de la connexion…

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / Orale gecombineerde antiretrovirale behandeling…
JoVE Journal
Immunology and Infection

Un abonnement à JoVE est nécessaire pour afficher ce contenu. Connectez-vous ou commencez votre essai gratuit.

JoVE Journal Immunology and Infection
Orale gecombineerde antiretrovirale behandeling bij hiv-1 geïnfecteerde gehumaniseerde muizen
RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells
Journal (Immunology and Infection)
RNAi Screening for Host Factors Involved in Vaccinia Virus Infection using Drosophila Cells
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Journal (Immunology and Infection)
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
 
Click here for the English version

Orale gecombineerde antiretrovirale behandeling bij hiv-1 geïnfecteerde gehumaniseerde muizen

Article DOI: 10.3791/63696-v • 06:07 min • October 6th, 2022
October 6th, 2022 •
1, 1, 1, 1, 1, 1, 1
1Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles

Chapitres

résumé
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Dit protocol beschrijft een nieuwe methode om orale gecombineerde antiretrovirale geneesmiddelen te leveren die met succes hiv-1-RNA-replicatie bij gehumaniseerde muizen onderdrukken.

Tags

Immunologie en infectie nummer 188
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter